BRANFORD, Conn., Dec. 7 /PRNewswire-FirstCall/ -- CAS Medical Systems, Inc. announced today that Financial Dynamics has been hired by the Company to provide proactive, strategic communications counsel specifically as it relates to media and investor relations.
Lou Scheps, President and CEO of CAS stated, “We have appointed Financial Dynamics to assist us with our communications as we enter the next exciting phase of our development. Financial Dynamics was chosen because of their sector knowledge, international reach and proven track record in advising companies in our industry.”
Declan Kelly, Chief Executive Officer of Financial Dynamics, commented, “We are pleased to have been appointed by CAS Medical Systems. The Company has been growing rapidly and is at an important stage in its lifecycle. We look forward to working with the Company’s management as they seek to raise their profile with key stakeholders.”
About CAS
Founded in 1984, CAS Medical Systems, Inc. is dedicated to the design and manufacture of innovative technologies and products vital to patient care in the most challenging clinical environments. Its current business segments include blood pressure measurement technology, vital signs monitoring equipment, apnea monitoring equipment and products for neonatal intensive care. With a reputation for the highest quality products available in the markets it serves, CAS products are used by clinicians worldwide. For more information, please visit http://www.casmed.com.
Financial Dynamics
Financial Dynamics is a leading global communications agency serving hundreds of corporations -- large and small, public and private -- with strategic communications programs and high-impact media relations. Financial Dynamics uses its international network, with headquarters in New York and London, to coordinate cross-border communications programs for some of the world’s most reputable corporate brands.
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future financial performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, commercialization and technological difficulties, and other risks detailed in the Company’s Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms “anticipate,” “believe,” “estimate,” “expect,” “may,” “objective,” “plan,” “possible,” “potential,” “project,” “will” and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information or otherwise.
Company Contacts: CAS Medical Jeffery Baird, CFO 203-488-6056 ir@casmed.com Financial Dynamics John Capodanno 212-850-5705 jcapodanno@fd-us.com
CAS Medical Systems, Inc.
CONTACT: Jeffery Baird, CFO of CAS Medical, +1-203-488-6056,ir@casmed.com; John Capodanno of Financial Dynamics, +1-212-850-5705,jcapodanno@fd-us.com
Web site: http://www.casmed.com/
